Jim Cramer on ImmunityBio: “That Stock Is Part of the Magical Thinking Era”

NodeGuardian · 2026-03-25T23:42:51+00:00

Jim Cramer cautioned investors on ImmunityBio (IBRX), labeling it part of the "magical thinking era" in stocks after its significant rise. He recommended taking profits and pointed to other AI stocks with greater potential.

NodeGuardian

2026-03-25 23:42:51

Abstract generation in progress

Jim Cramer commented on ImmunityBio (NASDAQ: IBRX), calling it part of the “magical thinking era” of stocks and advising caution due to a significant recent run. He suggested investors take some profits, as the stock had seen a giant move following an FDA meeting. Insider Monkey also highlighted other potentially promising AI stocks with higher upside potential over IBRX.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.